![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » CALPIS AND UNILEVER ENTER INTO A LICENCE AGREEMENT
CALPIS AND UNILEVER ENTER INTO A LICENCE AGREEMENT
July 5, 2005
Calpis has entered agreements with Unilever (Unilever PLC and Unilever N.V.) to license the technologies, patents and trademark and to provide the blood pressure regulating ingredient AmealPeptide for blood pressure controlling foods to be manufactured and sold by Unilever in Europe. As a result of this licensing agreement, Unilever will launch a blood pressure controlling dairy beverage incorporating AmealPeptide called "Becel/Flora pro activ" in Portugal this July, and gradually expand its sales area.
NPI Center (http://www.npicenter.com/anm/templates/newsATemp.aspx?articleid=12810&zoneid=12)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct